Bookmark

Add to MyYahoo RSS

MannKind News

News on MannKind (Ticker: MNKD) continually updated from thousands of sources around the net.

10 hrs ago | AmericanBankingNews.com

MannKind Given Average Rating of "Hold" by Analysts

MannKind has received a consensus recommendation of "Hold" from the nine brokerages that are currently covering the stock, AmericanBankingNews.com reports .

Comment?

Related Topix: Biotech

Sun Aug 31, 2014

AmericanBankingNews.com

MannKind Given Average Rating of "Hold" by Analysts

MannKind has received a consensus recommendation of "Hold" from the nine brokerages that are currently covering the stock, AmericanBankingNews.com reports .

Comment?

Related Topix: Biotech

Thu Aug 28, 2014

AmericanBankingNews.com

Short Interest in MannKind Increases By 6.6%

Shares of MannKind were the target of a large growth in short interest in August.

Comment?

Related Topix: Biotech

Wed Aug 27, 2014

AmericanBankingNews.com

Jefferies Group Initiates Coverage on MannKind

A number of other analysts have also recently weighed in on MNKD. Analysts at Zacks reiterated a "neutral" rating on shares of MannKind in a research note on Wednesday, August 13th.

Comment?

Related Topix: Biotech

Mon Aug 25, 2014

Seeking Alpha

MannKind: Moving From Short To Long?

My short thesis was spot on and investors following my advice to short the stock might want to consider taking profits off the table.

Comment?

Related Topix: Biotech, Food and Drug Administration, Medicine, Insulin (generic), Humulin, Novolin, Warren Buffett, Diabetes, Health

Wed Aug 20, 2014

Seeking Alpha

MannKind Corporation: Back To The Fundamentals

MannKind should be able to shed the "story stock" label in relatively short order and become less susceptible to the scurrilous attacks that have been common in recent years.

Comment?

Related Topix: Biotech, Financial Markets, Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health

Mon Aug 18, 2014

SchaeffersResearch.com

Most Active Options Update: MannKind Corporation

The 20 stocks listed in the table below have attracted the highest total options volume during the past 10 trading days.

Comment?

Related Topix: Biotech, Day Trading, Personal Finance

Sun Aug 17, 2014

Chemical & Engineering News

Mannkind Gets A Deal With Sanofi

The drug company MannKind has signed up Sanofi as a partner to sell Afrezza, the inhaled insulin it has long labored to get to market.

Comment?

Related Topix: Biotech, Medicine, Insulin (generic), Humulin, Novolin, Danbury, CT, Diabetes, Health

Fri Aug 15, 2014

Seeking Alpha

10 Known Unknowns That Matter For MannKind Investors

Many statements being made both by bulls and bears display a lack of understanding of the product itself, its potential market, or the business environment in which all diabetes drugs are sold.

Comment?

Related Topix: Biotech, Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin

Thu Aug 14, 2014

Seeking Alpha

10 Known Unknowns That Matter For MannKind Investors

Many statements being made both by bulls and bears display a lack of understanding of the product itself, its potential market, or the business environment in which all diabetes drugs are sold.

Comment?

Related Topix: Biotech, Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin

Wed Aug 13, 2014

Seeking Alpha

A Deeper Look At MannKind - Sanofi Deal And Valuation

The excitement of the new deal between MannKind and Sanofi has now been absorbed, and the street is now assessing how it feels the deal will impact MannKind.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Seeking Alpha

MannKind Q2 Earnings - Stock Sent To The Woodshed

Despite a massive drop in share price following the earnings event, I remain bullish on MannKind in light of the licensing agreement with Sanofi for Afrezza worldwide.

Comment?

Related Topix: Biotech

Tue Aug 12, 2014

AmericanBankingNews.com

MannKind Given New $13.00 Price Target at RBC Capital

RBC Capital's price target points to a potential upside of 52.40% from the stock's previous close.

Comment?

Related Topix: Biotech

Seeking Alpha

MannKind: Looking Beyond The Short-Term Disappointment

MannKind Corporation and France-based Sanofi announced early yesterday morning that they have entered into a worldwide exclusive licensing agreement for the development and commercialization of AfrezzaA , MannKind's recently approved rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.

Comment?

Related Topix: Biotech, Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health, Lantus, Insulin Glargine (generic), Marketing

Mon Aug 11, 2014

Seeking Alpha

MannKind's (MNKD) CEO Alfred Mann on Q2 2014 Results - Earnings Call Transcript

Welcome to the MannKind Corporation Second Quarter 2014 Conference Call. At this time, all participants are in a listen-only mode.

Comment?

Related Topix: Biotech, Corporate / Securities Law, Law

AmericanBankingNews.com

MannKind (MNKD) Posts Quarterly Results

MannKind issued its quarterly earnings data on Monday. The company reported earnings per share for the quarter, missing the consensus estimate of by $0.07, StockRatingsNetwork reports.

Comment?

Related Topix: Biotech

The Washington Post

U.S. Stock-Index Futures Advance as Russia Eases Ukraine Tension

U.S. stock-index futures rose, after the Standard & Poor's 500 Index posted its biggest gain in five months, amid continued investor optimism that the tension between Russia and Ukraine will ease.

Comment?

Related Topix: Biotech, Energy, Kinder Morgan, Oil & Gas, Banking, Deutsche Bank AG, Financial Services, Financial Markets, Science / Technology

Sun Aug 10, 2014

GlobeNewswire

Sanofi and MannKind Announce Global Licensing Agreement for...

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.

Comment?

Related Topix: Biotech, Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health, Food and Drug Administration

Fri Aug 08, 2014

GuruFocus.com

What This Upcoming Monday Means For MannKind Shareholders

As MannKind Corporation prepares to release its earnings report on Monday, August 11, both investors and short sellers wait in suspense.

Comment?

Related Topix: Biotech, Financial Services, American Physicians Service Group, Investment Services

AmericanBankingNews.com

MannKind (MNKD) Scheduled to Post Quarterly Earnings on Monday

MannKind is set to issue its Q214 quarterly earnings data on Monday, August 11th.

Comment?

Related Topix: Biotech

•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••